This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) features some interesting developments in microbiome therapeutics including gene edited bacteria, fecal microbiota transplants and other live biotherapeutics that can be used against a wide range of therapeutic indications.
• Developments in cell and gene therapies have also been covered, and a few developments around use of B cells for biotherapeutic production, allogeneic cell therapies, and mutation agnostic gene therapy are highlighted.
• The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
• The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled industry intelligence, technology advancements, and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.